Advanced search
Publication Cover
Expert Review of Vaccines Volume 3, 2004 - Issue 6
Submit an article Journal homepage
171
Views
96
CrossRef citations to date
0
Altmetric
Miscellaneous

Vaccination with Theratope® (STn-KLH) as treatment for breast cancer

Leona A Holmberg University of Washington School of Medicine, Department of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N. PO Box 19024, D5-390, Seattle, WA 98109-1024, USA. [email protected]
&
Brenda M Sandmaier University of Washington School of Medicine, Department of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N. PO Box 19024, D5-390, Seattle, WA 98109-1024, USA
Pages 655-663 | Published online: 09 Jan 2014

Citations (96)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Yuanjun Cheng, Yongbing Chen, Guohui Zang, Bin Chen, Jie Yao, Wenguang Zhang, Haibing Wang, Liu Yu, Pinghai He, Youming Zhang & Hanqing Wu. (2020) Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Cancer Management and Research 12, pages 1941-1946.
Read now
Quan Li, Wen-Xu Jin, Yi-Xiang Jin, Zhou-Ci Zheng, Xiao-Fen Zhou, Qing-Xuan Wang, Dan-Rong Ye, Yi-Han Sun, Xiao-Hua Zhang, Ou-Chen Wang, En-Dong Chen & Ye-Feng Cai. (2018) Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study. Cancer Management and Research 10, pages 1351-1358.
Read now
Josianne Nitcheu Tefit & Vincent Serra. (2011) Outlining novel cellular adjuvant products for therapeutic vaccines against cancer. Expert Review of Vaccines 10:8, pages 1207-1220.
Read now
Laura Cipolla, Ana C Araújo, Davide Bini, Luca Gabrielli, Laura Russo & Nasrin Shaikh. (2010) Discovery and design of carbohydrate-based therapeutics. Expert Opinion on Drug Discovery 5:8, pages 721-737.
Read now
Silvia von Mensdorff-Pouilly. (2010) Vaccine-induced antibody responses in patients with carcinoma. Expert Review of Vaccines 9:6, pages 579-594.
Read now
Philippe Fournier & Volker Schirrmacher. (2009) Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. Expert Review of Vaccines 8:1, pages 51-66.
Read now
Choon-Kit Tang, Maria Katsara & Vasso Apostolopoulos. (2008) Strategies used for MUC1 immunotherapy: human clinical studies. Expert Review of Vaccines 7:7, pages 963-975.
Read now
Jillian R. Brown, Brett E. Crawford & Jeffrey D. Esko. (2007) Glycan Antagonists and Inhibitors: A Fount for Drug Discovery. Critical Reviews in Biochemistry and Molecular Biology 42:6, pages 481-515.
Read now

Articles from other publishers (88)

Mahdi Kohansal Vajari, Mohammad-Javad Sanaei, Sina Salari, Alireza Rezvani, Mehrnaz Sadat Ravari & Davood Bashash. (2023) Breast cancer vaccination: Latest advances with an analytical focus on clinical trials. International Immunopharmacology 123, pages 110696.
Crossref
Yasuyuki Matsumoto & Tongzhong Ju. (2023) Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors. Cancers 15:14, pages 3536.
Crossref
René Roy & Leila Mousavifar. (2023) Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates. Chemical Society Reviews 52:10, pages 3353-3396.
Crossref
Ruka Ito, Keisuke Nagao & Kazuaki Ohtsubo. 2023. Glycosignals in Cancer. Glycosignals in Cancer 53 78 .
Kammila Martins Nicolau Costa, Demis Ferreira de Melo, Ingrid Larissa da Silva Soares, Bolívar Ponciano Goulart de Lima Damasceno & João Augusto Oshiro-Júnior. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 30 .
Yoshiyuki Manabe & Koichi Fukase. 2023. Glycolipids. Glycolipids 55 72 .
Deying Yang, Xiang Luo, Qinghai Lian, Lingqiang Gao, Chengxin Wang, Xiaoxiao Qi, Rong Zhang, Zhongqiu Liu & Guochao Liao. (2022) Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development. Acta Pharmaceutica Sinica B 12:12, pages 4432-4445.
Crossref
Sachin S. Shivatare, Vidya S. Shivatare & Chi-Huey Wong. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews 122:20, pages 15603-15671.
Crossref
Tsung-Che Chang, Yoshiyuki Manabe, Keita Ito, Ryuku Yamamoto, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Yukari Fujimoto, Chun-Cheng Lin & Koichi Fukase. (2022) Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope. RSC Advances 12:29, pages 18985-18993.
Crossref
Si-Yuan Zhu & Ke-Da Yu. (2022) Breast Cancer Vaccines: Disappointing or Promising?. Frontiers in Immunology 13.
Crossref
Nora Berois, Alvaro Pittini & Eduardo Osinaga. (2022) Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers 14:3, pages 645.
Crossref
Xiang Luo, Qinghai Lian, Wenwei Li, Liqing Chen, Renyu Zhang, Deying Yang, Lingqiang Gao, Xiaoxiao Qi, Zhongqiu Liu & Guochao Liao. (2021) Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development. Chemical Science 12:48, pages 15998-16013.
Crossref
Magdalena Thurin. (2021) Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 40:3, pages 89-100.
Crossref
Yuanjun Cheng, Qianru Fang, Yongbing Chen, Guohui Zang & Jie Yao. (2021) High Expression of Tumor Abnormal Protein Preoperatively Predicts Poor Prognosis of Patients With Esophageal Squamous Cell Carcinoma. Frontiers in Surgery 8.
Crossref
Divya Thomas, Ashok Kumar Rathinavel & Prakash Radhakrishnan. (2021) Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188464.
Crossref
Koichi Fukase. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience 166 184 .
Yoshiyuki Manabe, Atushi Shimoyama, Kazuya Kabayama & Koichi Fukase. 2021. Middle Molecular Strategy. Middle Molecular Strategy 3 20 .
Yoshiyuki Manabe, Tsung-Che Chang & Koichi Fukase. (2020) Recent advances in self-adjuvanting glycoconjugate vaccines. Drug Discovery Today: Technologies 37, pages 61-71.
Crossref
Pierre Rosenbaum, Cécile Artaud, Sylvie Bay, Christelle Ganneau, Mario Campone, Suzette Delaloge, Carole Gourmelon, Delphine Loirat, Jacques Medioni, François Pein, Marie-Paule Sablin, Olivier Tredan, Andrea Varga & Claude Leclerc. (2020) The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients. Cancer Immunology, Immunotherapy 69:5, pages 703-716.
Crossref
Julia Caroline Radosa, Lisa Stotz, Carolin Müller, Askin Canguel Kaya, Erich-Franz Solomayer & Marc Philipp Radosa. (2020) Clinical Data on Immunotherapy in Breast Cancer. Breast Care 15:5, pages 450-469.
Crossref
Cheorl-Ho KimCheorl-Ho Kim. 2020. Ganglioside Biochemistry. Ganglioside Biochemistry 193 214 .
Mikkel H. S. Marqvorsen, Can Araman & Sander I. van Kasteren. (2019) Going Native: Synthesis of Glycoproteins and Glycopeptides via Native Linkages To Study Glycan-Specific Roles in the Immune System. Bioconjugate Chemistry 30:11, pages 2715-2726.
Crossref
Jennifer Munkley & Emma Scott. (2019) Targeting Aberrant Sialylation to Treat Cancer. Medicines 6:4, pages 102.
Crossref
Chengcheng Song, Xiu-Jing Zheng, Haili Guo, Yafei Cao, Fan Zhang, Qin Li, Xin-Shan Ye & Yifa Zhou. (2019) Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response. Glycoconjugate Journal 36:5, pages 399-408.
Crossref
Sabine Heublein, Sabina Page, Doris Mayr, Elisa Schmoeckel, Fabian Trillsch, Frederik Marmé, Sven Mahner, Udo Jeschke & Aurelia Vattai. (2019) Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. International Journal of Molecular Sciences 20:2, pages 295.
Crossref
Liliana R. Loureiro, Diana P. Sousa, Dylan Ferreira, Wengang Chai, Luís Lima, Carina Pereira, Carla B. Lopes, Viviana G. Correia, Lisete M. Silva, Chunxia Li, Lúcio Lara Santos, José Alexandre Ferreira, Ana Barbas, Angelina S. Palma, Carlos Novo & Paula A. Videira. (2018) Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids. Scientific Reports 8:1.
Crossref
Tsung‐Che Chang, Yoshiyuki Manabe, Yukari Fujimoto, Shino Ohshima, Yoshie Kametani, Kazuya Kabayama, Yuka Nimura, Chun‐Cheng Lin & Koichi Fukase. (2018) Syntheses and Immunological Evaluation of Self‐Adjuvanting Clustered N ‐Acetyl and N ‐Propionyl Sialyl‐Tn Combined with a T‐helper Cell Epitope as Antitumor Vaccine Candidates . Angewandte Chemie International Edition 57:27, pages 8219-8224.
Crossref
Tsung‐Che Chang, Yoshiyuki Manabe, Yukari Fujimoto, Shino Ohshima, Yoshie Kametani, Kazuya Kabayama, Yuka Nimura, Chun‐Cheng Lin & Koichi Fukase. (2018) Syntheses and Immunological Evaluation of Self‐Adjuvanting Clustered N ‐Acetyl and N ‐Propionyl Sialyl‐Tn Combined with a T‐helper Cell Epitope as Antitumor Vaccine Candidates . Angewandte Chemie 130:27, pages 8351-8356.
Crossref
Dapeng Zhou, Lan Xu, Wei Huang & Torsten Tonn. (2018) Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules 23:6, pages 1326.
Crossref
Meng‐Man Wei, Yong‐Shi Wang & Xin‐Shan Ye. (2018) Carbohydrate‐based vaccines for oncotherapy. Medicinal Research Reviews 38:3, pages 1003-1026.
Crossref
Chengcheng Song, Xiu-Jing Zheng, Chang-Cheng Liu, Yifa Zhou & Xin-Shan Ye. (2017) A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model. Oncotarget 8:29, pages 47330-47343.
Crossref
Rutika Kokate. (2017) A Systematic Overview of Cancer Immunotherapy: An Emerging Therapy. Pharmacy & Pharmacology International Journal 5:2.
Crossref
J. Rojo, A. Sousa-Herves & A. Mascaraque. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 577 610 .
Marcela A. Haro, Chad A. Littrell, Zhaojun Yin, Xuefei Huang & Karen M. Haas. (2016) PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors. Cancer Immunology Research 4:12, pages 1027-1037.
Crossref
Andreia Almeida & Daniel Kolarich. (2016) The promise of protein glycosylation for personalised medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:8, pages 1583-1595.
Crossref
Joanne Chia, Germaine Goh & Frederic Bard. (2016) Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:8, pages 1623-1639.
Crossref
Feng Lan, Ming Zhu, Qiufeng Qi, Yaping Zhang & Yongping Liu. (2016) Prognostic value of serum tumor abnormal protein in gastric cancer patients. Molecular and Clinical Oncology.
Crossref
Jennifer Munkley. (2016) The Role of Sialyl-Tn in Cancer. International Journal of Molecular Sciences 17:3, pages 275.
Crossref
José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, Cristiana Gaiteiro, Celso A. Reis, Yehuda G. Assaraf & Lúcio Lara Santos. (2016) Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation. Drug Resistance Updates 24, pages 34-54.
Crossref
Liliana Loureiro, Mylène Carrascal, Ana Barbas, José Ramalho, Carlos Novo, Philippe Delannoy & Paula Videira. (2015) Challenges in Antibody Development against Tn and Sialyl-Tn Antigens. Biomolecules 5:3, pages 1783-1809.
Crossref
Lei Qiu, Jie Li, Shichong Yu, Qianli Wang, Yinghua Li, Zhenlin Hu, Qiuye Wu, Zhongwu Guo & Junping Zhang. (2015) A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells. Oncotarget 6:7, pages 5195-5203.
Crossref
Krishna Pillai, Mohammad H. Pourgholami, Terence C. Chua & David L. Morris. (2015) MUC1 as a Potential Target in Anticancer Therapies. American Journal of Clinical Oncology 38:1, pages 108-118.
Crossref
Yan Zhang & Fengshan Wang. (2015) Carbohydrate drugs: current status and development prospect. Drug Discoveries & Therapeutics 9:2, pages 79-87.
Crossref
Paula A Videira. (2015) Sweet side of bladder cancer. World Journal of Clinical Urology 4:3, pages 104.
Crossref
Pamela Thompson, Vani Lakshminarayanan, Nitin T. Supekar, Judy M. Bradley, Peter A. Cohen, Margreet A. Wolfert, Sandra J. Gendler & Geert-Jan Boons. (2015) Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide. Chemical Communications 51:50, pages 10214-10217.
Crossref
Chang-Xin Huo, Xiu-Jing Zheng, An Xiao, Chang-Cheng Liu, Shuang Sun, Zhuo Lv & Xin-Shan Ye. (2015) Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates. Organic & Biomolecular Chemistry 13:12, pages 3677-3690.
Crossref
Hsin-Yu Lee, Chien-Yu Chen, Tsung-I Tsai, Shiou-Ting Li, Kun-Hsien Lin, Yang-Yu Cheng, Chien-Tai Ren, Ting-Jen R. Cheng, Chung-Yi Wu & Chi-Huey Wong. (2014) Immunogenicity Study of Globo H Analogues with Modification at the Reducing or Nonreducing End of the Tumor Antigen. Journal of the American Chemical Society 136:48, pages 16844-16853.
Crossref
Fang Fang, Jichun Ma, Weihua Ni, Fengli Wang, Xiaxia Sun, Yingying Li, Qiongshu Li, Fei Xie, Juan Wang, Ruiping Zhai, Zhonghui Liu, Sunjun Gao & Guixiang Tai. (2014) MUC1 and maltose‑binding protein recombinant fusion protein combined with Bacillus Calmette‑Guerin induces MUC1‑specific and nonspecific anti‑tumor immunity in mice. Molecular Medicine Reports.
Crossref
Mylène A. Carrascal, Paulo F. Severino, M. Guadalupe Cabral, Mariana Silva, José Alexandre Ferreira, Fernando Calais, Hermínia Quinto, Cláudia Pen, Dário Ligeiro, Lúcio Lara Santos, Fabio Dall'Olio & Paula A. Videira. (2014) Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Molecular Oncology 8:3, pages 753-765.
Crossref
Deana Toussi & Paola Massari. (2014) Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines 2:2, pages 323-353.
Crossref
Philippe Saudan & Martin F. Bachmann. 2013. Vaccines. Vaccines 1138 1145 .
Lei Qiu, Xi Gong, Qianli Wang, Jie Li, Honggang Hu, Qiuye Wu, Junping Zhang & Zhongwu Guo. (2012) Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy. Cancer Immunology, Immunotherapy 61:11, pages 2045-2054.
Crossref
Sylvain Julien, Paula A. Videira & Philippe Delannoy. (2012) Sialyl-Tn in Cancer: (How) Did We Miss the Target?. Biomolecules 2:4, pages 435-466.
Crossref
Chang-Cheng Liu & Xin-Shan Ye. (2012) Carbohydrate-based cancer vaccines: target cancer with sugar bullets. Glycoconjugate Journal 29:5-6, pages 259-271.
Crossref
Yalong Zhang, Saddam M. Muthana, David Farnsworth, Olaf Ludek, Kristie Adams, Joseph J. BarchiJr.Jr. & Jeffrey C. Gildersleeve. (2012) Enhanced Epimerization of Glycosylated Amino Acids During Solid-Phase Peptide Synthesis. Journal of the American Chemical Society 134:14, pages 6316-6325.
Crossref
Nuhad K. Ibrahim, Kemal O. Yariz, Ihor Bondarenko, Alexei Manikhas, Vladimir Semiglazov, Anna Alyasova, Volodymyr Komisarenko, Yaroslav Shparyk, James Lee Murray, David Jones, Shai Senderovich, Albert Chau, Fredrik Erlandsson, Gary Acton & Mark Pegram. (2011) Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer. Clinical Cancer Research 17:21, pages 6822-6830.
Crossref
Jamie Heimburg-Molinaro, Michelle Lum, Geraldine Vijay, Miten Jain, Adel Almogren & Kate Rittenhouse-Olson. (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29:48, pages 8802-8826.
Crossref
Laura Morelli, Laura Poletti & Luigi Lay. (2011) Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation. European Journal of Organic Chemistry 2011:29, pages 5723-5777.
Crossref
David MilesHenri RochéMiguel MartinTimothy J. PerrenDavid A. CameronJohn GlaspyDavid DodwellJoanne ParkerJosé MayordomoAlejandro TresJames Lee Murray & Nuhad K. Ibrahim. (2011) Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer. The Oncologist 16:8, pages 1092-1100.
Crossref
Qianli Wang & Zhongwu Guo. (2011) Synthetic and Immunological Studies of sTn Derivatives Carrying Substituted Phenylacetylsialic Acids as Cancer Vaccine Candidate. ACS Medicinal Chemistry Letters 2:5, pages 373-378.
Crossref
Fan Yang, Xiu-Jing Zheng, Chang-Xin Huo, Yue Wang, Ye Zhang & Xin-Shan Ye. (2011) Enhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn Antigen. ACS Chemical Biology 6:3, pages 252-259.
Crossref
A. Kantele, M. P. Häkkinen, J. Zivny, C. O. Elson, J. Mestecky & J. M. Kantele. (2011) Humoral Immune Response to Keyhole Limpet Haemocyanin, the Protein Carrier in Cancer Vaccines. Clinical and Developmental Immunology 2011, pages 1-6.
Crossref
Luigi Buonaguro, Annacarmen Petrizzo, Maria Lina Tornesello & Franco M. Buonaguro. (2011) Translating Tumor Antigens into Cancer Vaccines. Clinical and Vaccine Immunology 18:1, pages 23-34.
Crossref
Li Ding, Hai Yu, Kam Lau, Yanhong Li, Saddam Muthana, Junru Wang & Xi Chen. (2011) Efficient chemoenzymatic synthesis of sialyl Tn-antigens and derivatives. Chemical Communications 47:30, pages 8691.
Crossref
Zhao Cao, Yu Feng, Hongfei Wei, Mingli Fang, Xiaoping Hu, Yongli Yu, Liying Wang & Min Wan. (2010) Purification of clinical‐grade recombinant HSP65‐MUC1 fusion protein. Biotechnology and Applied Biochemistry 57:1, pages 9-15.
Crossref
Sk Sahabuddin, Tsung-Che Chang, Chang-Ching Lin, Fan-Dan Jan, Hsuan-Yi Hsiao, Kuo-Ting Huang, Jeen-Han Chen, Jia-Cherng Horng, Ja-an Annie Ho & Chun-Cheng Lin. (2010) Synthesis of N-modified sTn analogs and evaluation of their immunogenicities by microarray-based immunoassay. Tetrahedron 66:38, pages 7510-7519.
Crossref
Richard E Beatson, Joyce Taylor-Papadimitriou & Joy M Burchell. (2010) MUC1 immunotherapy. Immunotherapy 2:3, pages 305-327.
Crossref
Karel Bezouška, Renata Šnajdrová, Karel Křenek, Markéta Vančurová, Alan Kádek, David Adámek, Pavel Lhoták, Daniel Kavan, Kateřina Hofbauerová, Petr Man, Pavla Bojarová & Vladimír Křen. (2010) RETRACTED: Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands. Bioorganic & Medicinal Chemistry 18:4, pages 1434-1440.
Crossref
Qianli Wang & Zhongwu Guo. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II 91 122 .
Pierre Stallforth, Bernd Lepenies, Alexander Adibekian & Peter H. Seeberger. (2009) Carbohydrates: A Frontier in Medicinal Chemistry. Journal of Medicinal Chemistry 52:18, pages 5561-5577.
Crossref
Tero Satomaa, Annamari Heiskanen, Iréne Leonardsson, Jonas Ångström, Anne Olonen, Maria Blomqvist, Noora Salovuori, Caj Haglund, Susann Teneberg, Jari Natunen, Olli Carpén & Juhani Saarinen. (2009) Analysis of the Human Cancer Glycome Identifies a Novel Group of Tumor-Associated N -Acetylglucosamine Glycan Antigens . Cancer Research 69:14, pages 5811-5819.
Crossref
Susan A. Brooks. 2009. Post‐translational Modification of Protein Biopharmaceuticals. Post‐translational Modification of Protein Biopharmaceuticals 15 49 .
Gary T. JenningsMartin F. Bachmann. (2009) Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases. Annual Review of Pharmacology and Toxicology 49:1, pages 303-326.
Crossref
Robert O. Dillman. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 669 678 .
Christopher W. Cluff. 2010. Lipid A in Cancer Therapy. Lipid A in Cancer Therapy 111 123 .
Asna Amin, Linda C. Benavides, Jarrod P. Holmes, Jeremy D. Gates, Mark G. Carmichael, Matthew T. Hueman, Elizabeth A. Mittendorf, Catherine E. Storrer, Yusuf H. Jama, Dianna Craig, Alex Stojadinovic, Sathibalan Ponniah & George E. Peoples. (2008) Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02. Cancer Immunology, Immunotherapy 57:12, pages 1817-1825.
Crossref
Ramon Colomer. (2008) Vacunas y cáncer de mama. Medicina Clínica 131:18, pages 692-693.
Crossref
Petr Niederhafner, Milan Reiniš, Jaroslav Šebestík & Jan Ježek. (2008) Glycopeptide dendrimers, Part III-a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases. Journal of Peptide Science 14:5, pages 556-587.
Crossref
Sandra Pinho, Nuno T. Marcos, Bibiana Ferreira, Ana S. Carvalho, Maria J. Oliveira, Filipe Santos-Silva, Anne Harduin-Lepers & Celso A. Reis. (2007) Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells. Cancer Letters 249:2, pages 157-170.
Crossref
Hai Yu, Harshal A. Chokhawala, Ajit Varki & Xi Chen. (2007) Efficient chemoenzymatic synthesis of biotinylated human serum albumin–sialoglycoside conjugates containing O-acetylated sialic acids. Org. Biomol. Chem. 5:15, pages 2458-2463.
Crossref
L. Mulard. (2007) Sucres et vaccins : du polysaccharide purifié au glycoconjugué semi-synthétique. Annales Pharmaceutiques Françaises 65:1, pages 14-32.
Crossref
M. Monsigny, A.-C. Roche, É. Duverger & O. Srinivas. 2007. Comprehensive Glycoscience. Comprehensive Glycoscience 477 521 .
Karl E. Krueger & Sudhir Srivastava. (2006) Posttranslational Protein Modifications. Molecular & Cellular Proteomics 5:10, pages 1799-1810.
Crossref
Liang Liao & France-Isabelle Auzanneau. (2006) Synthesis of Lewis A trisaccharide analogues in which d-glucose and l-rhamnose replace d-galactose and l-fucose, respectively. Carbohydrate Research 341:14, pages 2426-2433.
Crossref
B. Gückel. (2006) Vakzinierungen in der Therapie des MammakarzinomsVaccination in the therapy of breast cancer. Der Onkologe 12:3, pages 253-262.
Crossref
Zia A. Dehqanzada, Catherine E. Storrer, Matthew T. Hueman, Rebecca J. Foley, Katie A. Harris, Yusuf H. Jama, Tzu-Cheg Kao, Craig D. Shriver, Sathibalan Ponniah & George E. Peoples. (2006) Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/ neu Vaccine-Related Immunity in Breast Cancer Patients . Clinical Cancer Research 12:2, pages 478-486.
Crossref
Danielle H. Dube & Carolyn R. Bertozzi. (2005) Glycans in cancer and inflammation — potential for therapeutics and diagnostics. Nature Reviews Drug Discovery 4:6, pages 477-488.
Crossref
Chin-Fen Teo, Tzann-Shun Hwang, Pei-Heng Chen, Chih-Hung Hung, Heau-Shan Gao, Lee-Shang Chang & Chun-Hung Lin. (2005) Synthesis of Sialyl TN Glycopeptides - Enzymatic Sialylation by α2,6-Sialyltransferase fromPhotobacterium damsela. Advanced Synthesis & Catalysis 347:7-8, pages 967-972.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.